Stay updated on GeneNews LimitedPress Releases

Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest website image capture
Clouds background image

Latest updates to the GeneNews LimitedPress Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    New March 2026 press releases were added (e.g., persevErA study update and ALLEGORY data), and several December 2025 releases were removed.
    Difference
    3%
    Check dated 2026-03-11T17:25:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The press releases listing now includes a new item: Genentech's Fenebrutinib press release (01 Mar 2026), increasing the total results to 493. An older press release entry (08 Dec 2025) was removed from the listing.
    Difference
    1%
    Check dated 2026-03-04T14:32:14.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Adds two new press releases dated 19 Feb 2026 (FDA NDA for Giredestrant in ESR1-mutated, ER-positive breast cancer and FDA approval of Genentech’s Venclexta Plus Acalabrutinib for untreated CLL) and introduces the Population Health category. Removes two older entries from Nov 2025 related to Giredestrant and Fenebrutinib.
    Difference
    3%
    Check dated 2026-02-25T10:21:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new press release entry 'Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease' dated 15 Feb 2026, bringing the total results to 490. Removed the older entry 'Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025' dated 03 Nov 2025 from the listing.
    Difference
    0.8%
    Check dated 2026-02-18T07:49:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new press release dated 07 Feb 2026 about Fenebrutinib was added to the list. A press release from 02 Nov 2025 about Gazyva was removed.
    Difference
    0.8%
    Check dated 2026-02-11T09:25:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a new press release entry 'Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity' (26 Jan 2026) and increased the total to 488. Removed an older release 'Positive Phase III Results for Genentech’s Gazyva in Children and Young Adults With Idiopathic Nephrotic Syndrome' (27 Oct 2025).
    Difference
    0.8%
    Check dated 2026-01-28T04:05:02.000Z thumbnail image

Stay in the know with updates to GeneNews LimitedPress Releases

Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.